CD4 and myeloid sarcoma: Additionally, reductions in CD4+CD45RO+, CD8+, CD8+CD28−, and CD8+CD45RO+ (% and cells/μL) have been correlated with decreased MS [92,116], further suggesting improvements in obesity-related inflammation [68].